Triple M Overlap Syndrome: A Rare Complication of Immune Checkpoint Inhibitors

By afschroeder • October 8, 2026

Morris B. Triple M Overlap Syndrome: A Rare Complication of Immune Checkpoint Inhibitors. Cureus. 2026 Sep 6;18(9):e115859. doi: 10.7759/cureus.115859. PMID: 42841091; PMCID: PMC13641304.

Tags: cancer immunotherapy, General Internal Medicine, hepatic tumors, immune therapy mediated myocarditis, Inflammatory myositis, myasthenic crisis, Primary Care, Publications

Longitudinal Risk Factors for Incident Lung Cancer Among a Mixed HIV Serostatus Cohort of Sexual Minority Men in the United States

Qian Y, Zhang ZF, Comulada WS, Hidalgo MA, Lee SJ, Friedman MR, Palella FJ, Plankey MW, D'Souza G, Detels R, Mimiaga MJ. Longitudinal Risk Factors[...]

Dietary intake of vitamins B1, B2, B3, and B6, and the risk of gastric cancer: pooled analyses within the Stomach cancer Pooling (Stop) project

Collatuzzo G, Pelucchi C, Sassano M, Bonzi R, Vioque J, Gonzales-Palacios S, Seyyedsalehi MS, Lunet N, Morais S, Castaño-Vinyals G, Larrea-Baz NF, Ferraroni M, Zaridze[...]

Creating nurturing environments: Addressing domestic violence to improve early childhood development outcomes

Bhuwania P, Raub A, Martin A, Heymann J. Creating nurturing environments: Addressing domestic violence to improve early childhood development outcomes. Glob Public Health. 2026 Dec[...]